DocDollars

Biohaven Pharmaceutical Holding Company Ltd.

NY · United States · Reporting entity ID 100001106888

Total reported 2019–2025
$46.5M
#186 of 2,960 reporting companies — 0.1% of all reported industry payments
$13.4M in general payments across 220,463 records, plus $33.1M in research funding across 9,337 records.

How it breaks down

General payments $13,405,588
Research funding $33,075,271

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Biohaven Pharmaceutical Holding Company Ltd. reported $46.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #186 of 2,960 reporting companies. 71% of that was research funding and 29% general payments such as consulting, speaking, food and travel. 220,463 general payment records and 9,337 research records were filed.

Common questions about Biohaven Pharmaceutical Holding Company Ltd.

How much has Biohaven Pharmaceutical Holding Company Ltd. paid US doctors?

Biohaven Pharmaceutical Holding Company Ltd. reported $46,480,859 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $13,405,588 in general payments, $33,075,271 in research funding.

How does Biohaven Pharmaceutical Holding Company Ltd. rank among drug and device companies?

It ranks #186 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Biohaven Pharmaceutical Holding Company Ltd. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.